Search
for
Sort by
Research 91–120 of 108
- Dermatological, Trichological and Quality of Life Consequences of GLP ‐1 Receptor Agonist‐Mediated Weight Loss: A US Cross‐Sectional Survey
- Mechanisms of Impaired Skeletal Muscle Regeneration and Therapeutic Approaches in Aging and Chronic Disease
- Clinical Insights and Prognostic Factors in Frontal Fibrosing Alopecia and Lichen Planopilaris: A Retrospective Cohort Study
- Skin as a Metabolic Organ: Dermatologic Markers of Morbid Obesity and Their Role in Risk Stratification and Treatment Monitoring
- Modern Polycystic Ovary Syndrome (PCOS) Management: Intelligent Drug Delivery and Metabolic Reprogramming for Ovarian Restoration and Fertility Optimization
- Effects of Glucagon-like Peptide-1 Receptor Agonists on Skin Homeostasis and Skin Aging Processes
- The Impact of GLP-1 Receptor Agonists on Hair: Beneficial Effects or Adverse Outcomes?
- Methylene blue protects hair follicle stem cells from oxidative and metabolic stress to enhance hair regeneration
- Injectable Biostimulator in Adipose Tissue: An Update and Literature Review
- A New Framework for Understanding Hair‐Driven Medical Decisions
- Abstracts from the 2024 WDS Forum - virtual option
- Exploring links between acne and metabolic syndrome: a narrative review
- The 46th Annual Meeting of the Irish Endocrine Society Meeting Programme and Abstracts 2022
- Selected abstracts from the 47th meeting of the Irish Endocrine Society Sligo, 24th & 25th November 2023
- “From evidence to practice” – Insights from the multidisciplinary team on the optimal integration of GLP‐1 receptor agonists in obesity management services
- Ayurveda & Bioactives as Adjuvant for Dna Modulation in Cancer Treatment & Adverse Drug Reaction [ADR] – A Glimpse of Traditional Indian Nanotechnology
- The Potential Utility of Tirzepatide for the Management of Polycystic Ovary Syndrome
- TRANSPLANTE CAPILAR COM EXTRAÇÃO DE UNIDADE FOLICULAR: CUIDADOS DIRECIONADOS AOS EVENTOS ESPERADOS E COMPLICAÇÕES PÓS-OPERATÓRIAS
- Semaglutide Treatment of Excessive Body Weight in Obese PCOS Patients Unresponsive to Lifestyle Programs
- Alopecia and Semaglutide: Connecting the Dots for Patient Safety
- Dermatological adverse reactions and therapeutic potential of semaglutide, liraglutide and tirzepatide: Analysis of UK pharmacovigilance data and literature review
- New-Onset Alopecia Is Significantly Higher with Tirzepatide than with Semaglutide, Even After Weight-Loss Matching
- Semaglutide and the Skin: An Overview of Current Evidence
- Semaglutide-Induced Atypical Pustular Drug Eruption: A Case Report
- 53028 Semaglutide and Hair Loss: A Real-World Analysis
- Semaglutide as a Cornerstone Therapy in Obesity: Clinical and Pharmacological Insights
- Semaglutide-associated worsening of atypical anorexia nervosa in an adolescent girl: case report
- GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects
- Risk of Suicide, Hair Loss, and Aspiration with GLP1-Receptor Agonists and Other Diabetic Agents: A Real-World Pharmacovigilance Study
- Targeting Obesity in PCOS: A Review of Current Pharmacological Interventions and Future Directions